322 related articles for article (PubMed ID: 21372715)
1. Role of aspirin desensitization in the management of chronic rhinosinusitis.
Rizk H
Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):210-7. PubMed ID: 21372715
[TBL] [Abstract][Full Text] [Related]
2. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
Klimek L; Dollner R; Pfaar O; Mullol J
Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis.
Williams AN; Woessner KM
Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844
[TBL] [Abstract][Full Text] [Related]
4. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
Lee JY; Simon RA
Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867
[No Abstract] [Full Text] [Related]
5. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
Levy JM; Smith TL
Laryngoscope; 2017 Apr; 127(4):776-777. PubMed ID: 27813100
[No Abstract] [Full Text] [Related]
6. Aspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triad.
Mardiney M; Borish L
Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1287. PubMed ID: 11587618
[No Abstract] [Full Text] [Related]
7. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
8. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
9. Upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim JH; Park HS
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
[TBL] [Abstract][Full Text] [Related]
10. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim MA; Park HS
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
Front Immunol; 2021; 12():695815. PubMed ID: 34305932
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.
Platt M; Metson R; Stankovic K
Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):23-8. PubMed ID: 19532090
[TBL] [Abstract][Full Text] [Related]
13. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
15. Desensitization to aspirin in aspirin-sensitive patients with rhino-sinusitis and asthma: a review.
Knight A
J Otolaryngol; 1989 Jun; 18(4):165-7. PubMed ID: 2661852
[TBL] [Abstract][Full Text] [Related]
16. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
Dursun AB; Woessner KA; Simon RA; Karasoy D; Stevenson DD
Ann Allergy Asthma Immunol; 2008 May; 100(5):420-5. PubMed ID: 18517072
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to nonsteroidal anti-inflammatory drugs.
Namazy JA; Simon RA
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
[TBL] [Abstract][Full Text] [Related]
18. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.
Fruth K; Pogorzelski B; Schmidtmann I; Springer J; Fennan N; Fraessdorf N; Boessert A; Schaefer D; Gosepath J; Mann WJ
Allergy; 2013; 68(5):659-65. PubMed ID: 23464577
[TBL] [Abstract][Full Text] [Related]
20. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
